×

PTGFRN cDNA ORF clone, Homo sapiens(Human)

Gene Symbol PTGFRN
Entrez Gene ID 5738
Full Name prostaglandin F2 receptor inhibitor
Synonyms CD315,CD9P-1,EWI-F,FPRP,SMAP-6
General protein information
Preferred Names

prostaglandin F2 receptor inhibitor

Names

prostaglandin F2 receptor negative regulator
CD9 partner 1
glu-Trp-Ile EWI motif-containing protein F
prostaglandin F2-alpha receptor regulatory protein
prostaglandin F2-alpha receptor-associated protein

Gene Type protein-coding
Organism Homo sapiens(Human)
Genome

1

1p13.1

Disorder MIM:

601204


mRNA and Protein(s)

mRNA Protein Name
XM_017001874.1 XP_016857363.1 prostaglandin F2 receptor negative regulator isoform X1
NM_020440.3 NP_065173.2 prostaglandin F2 receptor negative regulator precursor



Bos taurus (cattle) PTGFRN XP_002686168.2
Canis lupus familiaris (dog) PTGFRN XP_005630930.1
Mus musculus (house mouse) Ptgfrn NP_035327.2
Xenopus tropicalis (tropical clawed frog) LOC100493252 XP_002943881.2
Rattus norvegicus (Norway rat) Ptgfrn NP_062116.1
Danio rerio (zebrafish) si:ch211-132g1.7 XP_005168370.1
Macaca mulatta (rhesus monkey) PTGFRN XP_001103382.2
Homo sapiens (human) PTGFRN NP_065173.2
Pan troglodytes (chimpanzee) PTGFRN XP_003308360.1
Gallus gallus (chicken) PTGFRN XP_416660.4


Related articles in PubMed

CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth.
Guilmain W, Colin S, Legrand E, Vannier JP, Steverlynck C, Bongaerts M, Vasse M, Al-Mahmood S
British journal of cancer104(3)496-504(2011 Feb)

Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.
Kerns SL, Ostrer H, Stock R, Li W, Moore J, Pearlman A, Campbell C, Shao Y, Stone N, Kusnetz L, Rosenstein BS
International journal of radiation oncology, biology, physics78(5)1292-300(2010 Dec)

Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches.
Ikeda M, Tomita Y, Mouri A, Koga M, Okochi T, Yoshimura R, Yamanouchi Y, Kinoshita Y, Hashimoto R, Williams HJ, Takeda M, Nakamura J, Nabeshima T, Owen MJ, O'Donovan MC, Honda H, Arinami T, Ozaki N, Iwata N
Biological psychiatry67(3)263-9(2010 Feb)

In situ chemical cross-linking on living cells reveals CD9P-1 cis-oligomer at cell surface.
André M, Chambrion C, Charrin S, Soave S, Chaker J, Boucheix C, Rubinstein E, Le Naour F
Journal of proteomics73(1)93-102(2009 Nov)

Quantitative proteomics identifies a Dab2/integrin module regulating cell migration.
Teckchandani A, Toida N, Goodchild J, Henderson C, Watts J, Wollscheid B, Cooper JA
The Journal of cell biology186(1)99-111(2009 Jul)

GeneRIFs: Gene References Into Functions What's a GeneRIF?

These findings show for the first time that CD9P-1 expression positively correlates with the metastatic status of human lung tumor
Title: CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth.

Observational study and genome-wide association study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)
Title: Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches.

Tetraspanins can play a role on CD9P-1 oligomerization status.
Title: In situ chemical cross-linking on living cells reveals CD9P-1 cis-oligomer at cell surface.

CD9P-1 was shown to exhibit more than 40 different N-glycans, essentially composed of complex and high mannose-type structures.
Title: Glycosylation status of the membrane protein CD9P-1.

transferrin receptor and CD9, CD81, and CD9P-1 are differentially sorted into exosomes after TPA treatment of K562 cells
Title: The transferrin receptor and the tetraspanin web molecules CD9, CD81, and CD9P-1 are differentially sorted into exosomes after TPA treatment of K562 cells.

The following PTGFRN gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the PTGFRN cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.

Online Only Promotion

Up to 50% OFF! Starting
from $49/clone

***CloneID RefSeq Accession Definition **Vector *Turnaround time Price (USD) Select
OHu60007 NM_020440.3
Latest version!
Homo sapiens prostaglandin F2 receptor inhibitor (PTGFRN), mRNA. pcDNA3.1+/C-(K)DYK or customized vector 12-14 $265.30
$379.00
OHu90298 XM_017001874.1
Latest version!
Homo sapiens prostaglandin F2 receptor inhibitor (PTGFRN), transcript variant X1, mRNA. pcDNA3.1+/C-(K)DYK or customized vector 14-16 $475.30
$679.00

ORF Online Only Promotion

Next-day Shipping ORF Clones ( in default vector with tag)
1 Clone 30% OFF
2-4 Clone 40% OFF
5 or more Clone 50% OFF
All Other ORF Clones
30% OFF

*Business Day

** You may select a custom vector to replace pcDNA3.1+/C-(K)DYK after clone is added to cart.

** GenScript guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories. In addition, please pay attention to the signal peptide, propeptide and transit peptide in target ORF, which may affect the choice of vector (N/C terminal tag vector).

***One clone ID might be correlated to multiple accession numbers, which share the same CDS sequence.


CloneID OHu60007
Clone ID Related Accession (Same CDS sequence) NM_020440.3
Accession Version NM_020440.3 Latest version! Documents for ORF clone product in dufault vector
Sequence Information ORF Nucleotide Sequence (Length: 2640bp)
Protein sequence
SNP
Vector pcDNA3.1+/C-(K)DYK or customized vector User Manual
Clone information Clone Map MSDS
Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
ORF Insert Method CloneEZ® Seamless cloning technology
Insert Structure linear
Update Date 2015-09-26
Organism Homo sapiens(Human)
Product prostaglandin F2 receptor negative regulator precursor
Comment VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from DA572787.1, AB037857.1, AK074637.1 and AA045111.1. On Dec 11, 2014 this sequence version replaced NM_020440.2. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: BC152454.1, AB037857.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA1966682, SAMEA1968189 [ECO:0000348] ##Evidence-Data-END##

1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021
1081
1141
1201
1261
1321
1381
1441
1501
1561
1621
1681
1741
1801
1861
1921
1981
2041
2101
2161
2221
2281
2341
2401
2461
2521
2581
ATGGGGCGCC TGGCCTCGAG GCCGCTGCTG CTGGCGCTCC TGTCGTTGGC TCTTTGCCGA 
GGGCGTGTGG TGAGAGTCCC CACAGCGACC CTGGTTCGAG TGGTGGGCAC TGAGCTGGTC
ATCCCCTGCA ACGTCAGTGA CTATGATGGC CCCAGCGAGC AAAACTTTGA CTGGAGCTTC
TCATCTTTGG GGAGCAGCTT TGTGGAGCTT GCAAGCACCT GGGAGGTGGG GTTCCCAGCC
CAGCTGTACC AGGAGCGGCT GCAGAGGGGC GAGATCCTGT TAAGGCGGAC TGCCAACGAC
GCCGTGGAGC TCCACATAAA GAACGTCCAG CCTTCAGACC AAGGCCACTA CAAATGTTCA
ACCCCCAGCA CAGATGCCAC TGTCCAGGGA AACTATGAGG ACACAGTGCA GGTTAAAGTG
CTGGCCGACT CCCTGCACGT GGGCCCCAGC GCGCGGCCCC CGCCGAGCCT GAGCCTGCGG
GAGGGGGAGC CCTTCGAGCT GCGCTGCACC GCCGCCTCCG CCTCGCCGCT GCACACGCAC
CTGGCGCTGC TGTGGGAGGT GCACCGCGGC CCGGCCAGGC GGAGCGTCCT CGCCCTGACC
CACGAGGGCA GGTTCCACCC GGGCCTGGGG TACGAGCAGC GCTACCACAG TGGGGACGTG
CGCCTCGACA CCGTGGGCAG CGACGCCTAC CGCCTCTCAG TGTCCCGGGC TCTGTCTGCC
GACCAGGGCT CCTACAGGTG TATCGTCAGC GAGTGGATCG CCGAGCAGGG CAACTGGCAG
GAAATCCAAG AAAAGGCCGT GGAAGTTGCC ACCGTGGTGA TCCAGCCATC AGTTCTGCGA
GCAGCTGTGC CCAAGAATGT GTCTGTGGCT GAAGGAAAGG AACTGGACCT GACCTGTAAC
ATCACAACAG ACCGAGCCGA TGACGTCCGG CCCGAGGTGA CGTGGTCCTT CAGCAGGATG
CCTGACAGCA CCCTACCTGG CTCCCGCGTG TTGGCGCGGC TTGACCGTGA TTCCCTGGTG
CACAGCTCGC CTCATGTTGC TTTGAGTCAT GTGGATGCAC GCTCCTACCA TTTACTGGTT
CGGGATGTTA GCAAAGAAAA CTCTGGCTAC TATTACTGCC ACGTGTCCCT GTGGGCACCC
GGACACAACA GGAGCTGGCA CAAAGTGGCA GAGGCCGTGT CTTCCCCAGC TGGTGTGGGT
GTGACCTGGC TAGAACCAGA CTACCAGGTG TACCTGAATG CTTCCAAGGT CCCCGGGTTT
GCGGATGACC CCACAGAGCT GGCATGCCGG GTGGTGGACA CGAAGAGTGG GGAGGCGAAT
GTCCGATTCA CGGTTTCGTG GTACTACAGG ATGAACCGGC GCAGCGACAA TGTGGTGACC
AGCGAGCTGC TTGCAGTCAT GGACGGGGAC TGGACGCTAA AATATGGAGA GAGGAGCAAG
CAGCGGGCCC AGGATGGAGA CTTTATTTTT TCTAAGGAAC ATACAGACAC GTTCAATTTC
CGGATCCAAA GGACTACAGA GGAAGACAGA GGCAATTATT ACTGTGTTGT GTCTGCCTGG
ACCAAACAGC GGAACAACAG CTGGGTGAAA AGCAAGGATG TCTTCTCCAA GCCTGTTAAC
ATATTTTGGG CATTAGAAGA TTCCGTGCTT GTGGTGAAGG CGAGGCAGCC AAAGCCTTTC
TTTGCTGCCG GAAATACATT TGAGATGACT TGCAAAGTAT CTTCCAAGAA TATTAAGTCG
CCACGCTACT CTGTTCTCAT CATGGCTGAG AAGCCTGTCG GCGACCTCTC CAGTCCCAAT
GAAACGAAGT ACATCATCTC TCTGGACCAG GATTCTGTGG TGAAGCTGGA GAATTGGACA
GATGCATCAC GGGTGGATGG CGTTGTTTTA GAAAAAGTGC AGGAGGATGA GTTCCGCTAT
CGAATGTACC AGACTCAGGT CTCAGACGCA GGGCTGTACC GCTGCATGGT GACAGCCTGG
TCTCCTGTCA GGGGCAGCCT TTGGCGAGAA GCAGCAACCA GTCTCTCCAA TCCTATTGAG
ATAGACTTCC AAACCTCAGG TCCTATATTT AATGCTTCTG TGCATTCAGA CACACCATCA
GTAATTCGGG GAGATCTGAT CAAATTGTTC TGTATCATCA CTGTCGAGGG AGCAGCACTG
GATCCAGATG ACATGGCCTT TGATGTGTCC TGGTTTGCGG TGCACTCTTT TGGCCTGGAC
AAGGCTCCTG TGCTCCTGTC TTCCCTGGAT CGGAAGGGCA TCGTGACCAC CTCCCGGAGG
GACTGGAAGA GCGACCTCAG CCTGGAGCGC GTGAGTGTGC TGGAATTCTT GCTGCAAGTG
CATGGCTCCG AGGACCAGGA CTTTGGCAAC TACTACTGTT CCGTGACTCC ATGGGTGAAG
TCACCAACAG GTTCCTGGCA GAAGGAGGCA GAGATCCACT CCAAGCCCGT TTTTATAACT
GTGAAGATGG ATGTGCTGAA CGCCTTCAAG TATCCCTTGC TGATCGGCGT CGGTCTGTCC
ACGGTCATCG GGCTCCTGTC CTGTCTCATC GGGTACTGCA GCTCCCACTG GTGTTGTAAG
AAGGAGGTTC AGGAGACACG GCGCGAGCGC CGCAGGCTCA TGTCGATGGA GATGGACTAG

The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

RefSeq NP_065173.2
CDS282..2921
Misc Feature(1)369..701
Misc Feature(2)396..644
Misc Feature(3)<591..704
Misc Feature(4)1092..1094
Misc Feature(5)1128..1409
Misc Feature(6)1131..1409
Misc Feature(7)1551..1562
Misc Feature(8)2388..2396
Misc Feature(9)2778..2840
Exon (1)1..330
Exon (2)331..699
Exon (3)700..1113
Exon (4)1114..1494
Exon (5)1495..1920
Exon (6)1921..2340
Exon (7)2341..2448
Exon (8)2449..2754
Exon (9)2755..6312
Translation

Target ORF information:

RefSeq Version NM_020440.3
Organism Homo sapiens(Human)
Definition Homo sapiens prostaglandin F2 receptor inhibitor (PTGFRN), mRNA.

Target ORF information:

Epitope DYKDDDDK
Bacterial selection AMPR
Mammalian selection NeoR
Vector pcDNA3.1+/C-(K)DYK
NM_020440.3

ORF Insert Sequence:

1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021
1081
1141
1201
1261
1321
1381
1441
1501
1561
1621
1681
1741
1801
1861
1921
1981
2041
2101
2161
2221
2281
2341
2401
2461
2521
2581
ATGGGGCGCC TGGCCTCGAG GCCGCTGCTG CTGGCGCTCC TGTCGTTGGC TCTTTGCCGA 
GGGCGTGTGG TGAGAGTCCC CACAGCGACC CTGGTTCGAG TGGTGGGCAC TGAGCTGGTC
ATCCCCTGCA ACGTCAGTGA CTATGATGGC CCCAGCGAGC AAAACTTTGA CTGGAGCTTC
TCATCTTTGG GGAGCAGCTT TGTGGAGCTT GCAAGCACCT GGGAGGTGGG GTTCCCAGCC
CAGCTGTACC AGGAGCGGCT GCAGAGGGGC GAGATCCTGT TAAGGCGGAC TGCCAACGAC
GCCGTGGAGC TCCACATAAA GAACGTCCAG CCTTCAGACC AAGGCCACTA CAAATGTTCA
ACCCCCAGCA CAGATGCCAC TGTCCAGGGA AACTATGAGG ACACAGTGCA GGTTAAAGTG
CTGGCCGACT CCCTGCACGT GGGCCCCAGC GCGCGGCCCC CGCCGAGCCT GAGCCTGCGG
GAGGGGGAGC CCTTCGAGCT GCGCTGCACC GCCGCCTCCG CCTCGCCGCT GCACACGCAC
CTGGCGCTGC TGTGGGAGGT GCACCGCGGC CCGGCCAGGC GGAGCGTCCT CGCCCTGACC
CACGAGGGCA GGTTCCACCC GGGCCTGGGG TACGAGCAGC GCTACCACAG TGGGGACGTG
CGCCTCGACA CCGTGGGCAG CGACGCCTAC CGCCTCTCAG TGTCCCGGGC TCTGTCTGCC
GACCAGGGCT CCTACAGGTG TATCGTCAGC GAGTGGATCG CCGAGCAGGG CAACTGGCAG
GAAATCCAAG AAAAGGCCGT GGAAGTTGCC ACCGTGGTGA TCCAGCCATC AGTTCTGCGA
GCAGCTGTGC CCAAGAATGT GTCTGTGGCT GAAGGAAAGG AACTGGACCT GACCTGTAAC
ATCACAACAG ACCGAGCCGA TGACGTCCGG CCCGAGGTGA CGTGGTCCTT CAGCAGGATG
CCTGACAGCA CCCTACCTGG CTCCCGCGTG TTGGCGCGGC TTGACCGTGA TTCCCTGGTG
CACAGCTCGC CTCATGTTGC TTTGAGTCAT GTGGATGCAC GCTCCTACCA TTTACTGGTT
CGGGATGTTA GCAAAGAAAA CTCTGGCTAC TATTACTGCC ACGTGTCCCT GTGGGCACCC
GGACACAACA GGAGCTGGCA CAAAGTGGCA GAGGCCGTGT CTTCCCCAGC TGGTGTGGGT
GTGACCTGGC TAGAACCAGA CTACCAGGTG TACCTGAATG CTTCCAAGGT CCCCGGGTTT
GCGGATGACC CCACAGAGCT GGCATGCCGG GTGGTGGACA CGAAGAGTGG GGAGGCGAAT
GTCCGATTCA CGGTTTCGTG GTACTACAGG ATGAACCGGC GCAGCGACAA TGTGGTGACC
AGCGAGCTGC TTGCAGTCAT GGACGGGGAC TGGACGCTAA AATATGGAGA GAGGAGCAAG
CAGCGGGCCC AGGATGGAGA CTTTATTTTT TCTAAGGAAC ATACAGACAC GTTCAATTTC
CGGATCCAAA GGACTACAGA GGAAGACAGA GGCAATTATT ACTGTGTTGT GTCTGCCTGG
ACCAAACAGC GGAACAACAG CTGGGTGAAA AGCAAGGATG TCTTCTCCAA GCCTGTTAAC
ATATTTTGGG CATTAGAAGA TTCCGTGCTT GTGGTGAAGG CGAGGCAGCC AAAGCCTTTC
TTTGCTGCCG GAAATACATT TGAGATGACT TGCAAAGTAT CTTCCAAGAA TATTAAGTCG
CCACGCTACT CTGTTCTCAT CATGGCTGAG AAGCCTGTCG GCGACCTCTC CAGTCCCAAT
GAAACGAAGT ACATCATCTC TCTGGACCAG GATTCTGTGG TGAAGCTGGA GAATTGGACA
GATGCATCAC GGGTGGATGG CGTTGTTTTA GAAAAAGTGC AGGAGGATGA GTTCCGCTAT
CGAATGTACC AGACTCAGGT CTCAGACGCA GGGCTGTACC GCTGCATGGT GACAGCCTGG
TCTCCTGTCA GGGGCAGCCT TTGGCGAGAA GCAGCAACCA GTCTCTCCAA TCCTATTGAG
ATAGACTTCC AAACCTCAGG TCCTATATTT AATGCTTCTG TGCATTCAGA CACACCATCA
GTAATTCGGG GAGATCTGAT CAAATTGTTC TGTATCATCA CTGTCGAGGG AGCAGCACTG
GATCCAGATG ACATGGCCTT TGATGTGTCC TGGTTTGCGG TGCACTCTTT TGGCCTGGAC
AAGGCTCCTG TGCTCCTGTC TTCCCTGGAT CGGAAGGGCA TCGTGACCAC CTCCCGGAGG
GACTGGAAGA GCGACCTCAG CCTGGAGCGC GTGAGTGTGC TGGAATTCTT GCTGCAAGTG
CATGGCTCCG AGGACCAGGA CTTTGGCAAC TACTACTGTT CCGTGACTCC ATGGGTGAAG
TCACCAACAG GTTCCTGGCA GAAGGAGGCA GAGATCCACT CCAAGCCCGT TTTTATAACT
GTGAAGATGG ATGTGCTGAA CGCCTTCAAG TATCCCTTGC TGATCGGCGT CGGTCTGTCC
ACGGTCATCG GGCTCCTGTC CTGTCTCATC GGGTACTGCA GCTCCCACTG GTGTTGTAAG
AAGGAGGTTC AGGAGACACG GCGCGAGCGC CGCAGGCTCA TGTCGATGGA GATGGACTAG

The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

CloneID OHu90298
Clone ID Related Accession (Same CDS sequence) XM_017001874.1
Accession Version XM_017001874.1 Latest version! Documents for ORF clone product in dufault vector
Sequence Information ORF Nucleotide Sequence (Length: 2658bp)
Protein sequence
SNP
Vector pcDNA3.1+/C-(K)DYK or customized vector User Manual
Clone information Clone Map MSDS
Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
ORF Insert Method CloneEZ® Seamless cloning technology
Insert Structure linear
Update Date 2016-06-06
Organism Homo sapiens(Human)
Product prostaglandin F2 receptor negative regulator isoform X1
Comment MODEL REFSEQ: This record is predicted by automated computational analysis. This record is derived from a genomic sequence (NC_000001.11) annotated using gene prediction method: Gnomon, supported by mRNA and EST evidence. Also see: Documentation of NCBI's Annotation Process ##Genome-Annotation-Data-START## Annotation Provider :: NCBI Annotation Status :: Full annotation Annotation Version :: Homo sapiens Annotation Release 108 Annotation Pipeline :: NCBI eukaryotic genome annotation pipeline Annotation Software Version :: 7.0 Annotation Method :: Best-placed RefSeq; Gnomon Features Annotated :: Gene; mRNA; CDS; ncRNA ##Genome-Annotation-Data-END##

1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021
1081
1141
1201
1261
1321
1381
1441
1501
1561
1621
1681
1741
1801
1861
1921
1981
2041
2101
2161
2221
2281
2341
2401
2461
2521
2581
2641
ATGCTCGGAG GAAATGCTCG TTGGAGCACT TTGGATTTTG GATTTTCAGA TTGGGAATCC 
TTAACTGCTC TTTGCCGAGG GCGTGTGGTG AGAGTCCCCA CAGCGACCCT GGTTCGAGTG
GTGGGCACTG AGCTGGTCAT CCCCTGCAAC GTCAGTGACT ATGATGGCCC CAGCGAGCAA
AACTTTGACT GGAGCTTCTC ATCTTTGGGG AGCAGCTTTG TGGAGCTTGC AAGCACCTGG
GAGGTGGGGT TCCCAGCCCA GCTGTACCAG GAGCGGCTGC AGAGGGGCGA GATCCTGTTA
AGGCGGACTG CCAACGACGC CGTGGAGCTC CACATAAAGA ACGTCCAGCC TTCAGACCAA
GGCCACTACA AATGTTCAAC CCCCAGCACA GATGCCACTG TCCAGGGAAA CTATGAGGAC
ACAGTGCAGG TTAAAGTGCT GGCCGACTCC CTGCACGTGG GCCCCAGCGC GCGGCCCCCG
CCGAGCCTGA GCCTGCGGGA GGGGGAGCCC TTCGAGCTGC GCTGCACCGC CGCCTCCGCC
TCGCCGCTGC ACACGCACCT GGCGCTGCTG TGGGAGGTGC ACCGCGGCCC GGCCAGGCGG
AGCGTCCTCG CCCTGACCCA CGAGGGCAGG TTCCACCCGG GCCTGGGGTA CGAGCAGCGC
TACCACAGTG GGGACGTGCG CCTCGACACC GTGGGCAGCG ACGCCTACCG CCTCTCAGTG
TCCCGGGCTC TGTCTGCCGA CCAGGGCTCC TACAGGTGTA TCGTCAGCGA GTGGATCGCC
GAGCAGGGCA ACTGGCAGGA AATCCAAGAA AAGGCCGTGG AAGTTGCCAC CGTGGTGATC
CAGCCATCAG TTCTGCGAGC AGCTGTGCCC AAGAATGTGT CTGTGGCTGA AGGAAAGGAA
CTGGACCTGA CCTGTAACAT CACAACAGAC CGAGCCGATG ACGTCCGGCC CGAGGTGACG
TGGTCCTTCA GCAGGATGCC TGACAGCACC CTACCTGGCT CCCGCGTGTT GGCGCGGCTT
GACCGTGATT CCCTGGTGCA CAGCTCGCCT CATGTTGCTT TGAGTCATGT GGATGCACGC
TCCTACCATT TACTGGTTCG GGATGTTAGC AAAGAAAACT CTGGCTACTA TTACTGCCAC
GTGTCCCTGT GGGCACCCGG ACACAACAGG AGCTGGCACA AAGTGGCAGA GGCCGTGTCT
TCCCCAGCTG GTGTGGGTGT GACCTGGCTA GAACCAGACT ACCAGGTGTA CCTGAATGCT
TCCAAGGTCC CCGGGTTTGC GGATGACCCC ACAGAGCTGG CATGCCGGGT GGTGGACACG
AAGAGTGGGG AGGCGAATGT CCGATTCACG GTTTCGTGGT ACTACAGGAT GAACCGGCGC
AGCGACAATG TGGTGACCAG CGAGCTGCTT GCAGTCATGG ACGGGGACTG GACGCTAAAA
TATGGAGAGA GGAGCAAGCA GCGGGCCCAG GATGGAGACT TTATTTTTTC TAAGGAACAT
ACAGACACGT TCAATTTCCG GATCCAAAGG ACTACAGAGG AAGACAGAGG CAATTATTAC
TGTGTTGTGT CTGCCTGGAC CAAACAGCGG AACAACAGCT GGGTGAAAAG CAAGGATGTC
TTCTCCAAGC CTGTTAACAT ATTTTGGGCA TTAGAAGATT CCGTGCTTGT GGTGAAGGCG
AGGCAGCCAA AGCCTTTCTT TGCTGCCGGA AATACATTTG AGATGACTTG CAAAGTATCT
TCCAAGAATA TTAAGTCGCC ACGCTACTCT GTTCTCATCA TGGCTGAGAA GCCTGTCGGC
GACCTCTCCA GTCCCAATGA AACGAAGTAC ATCATCTCTC TGGACCAGGA TTCTGTGGTG
AAGCTGGAGA ATTGGACAGA TGCATCACGG GTGGATGGCG TTGTTTTAGA AAAAGTGCAG
GAGGATGAGT TCCGCTATCG AATGTACCAG ACTCAGGTCT CAGACGCAGG GCTGTACCGC
TGCATGGTGA CAGCCTGGTC TCCTGTCAGG GGCAGCCTTT GGCGAGAAGC AGCAACCAGT
CTCTCCAATC CTATTGAGAT AGACTTCCAA ACCTCAGGTC CTATATTTAA TGCTTCTGTG
CATTCAGACA CACCATCAGT AATTCGGGGA GATCTGATCA AATTGTTCTG TATCATCACT
GTCGAGGGAG CAGCACTGGA TCCAGATGAC ATGGCCTTTG ATGTGTCCTG GTTTGCGGTG
CACTCTTTTG GCCTGGACAA GGCTCCTGTG CTCCTGTCTT CCCTGGATCG GAAGGGCATC
GTGACCACCT CCCGGAGGGA CTGGAAGAGC GACCTCAGCC TGGAGCGCGT GAGTGTGCTG
GAATTCTTGC TGCAAGTGCA TGGCTCCGAG GACCAGGACT TTGGCAACTA CTACTGTTCC
GTGACTCCAT GGGTGAAGTC ACCAACAGGT TCCTGGCAGA AGGAGGCAGA GATCCACTCC
AAGCCCGTTT TTATAACTGT GAAGATGGAT GTGCTGAACG CCTTCAAGTA TCCCTTGCTG
ATCGGCGTCG GTCTGTCCAC GGTCATCGGG CTCCTGTCCT GTCTCATCGG GTACTGCAGC
TCCCACTGGT GTTGTAAGAA GGAGGTTCAG GAGACACGGC GCGAGCGCCG CAGGCTCATG
TCGATGGAGA TGGACTAG

The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

RefSeq XP_016857363.1
CDS35..2692
Translation

Target ORF information:

RefSeq Version XM_017001874.1
Organism Homo sapiens(Human)
Definition Homo sapiens prostaglandin F2 receptor inhibitor (PTGFRN), transcript variant X1, mRNA.

Target ORF information:

Epitope DYKDDDDK
Bacterial selection AMPR
Mammalian selection NeoR
Vector pcDNA3.1+/C-(K)DYK
XM_017001874.1

ORF Insert Sequence:

1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021
1081
1141
1201
1261
1321
1381
1441
1501
1561
1621
1681
1741
1801
1861
1921
1981
2041
2101
2161
2221
2281
2341
2401
2461
2521
2581
2641
ATGCTCGGAG GAAATGCTCG TTGGAGCACT TTGGATTTTG GATTTTCAGA TTGGGAATCC 
TTAACTGCTC TTTGCCGAGG GCGTGTGGTG AGAGTCCCCA CAGCGACCCT GGTTCGAGTG
GTGGGCACTG AGCTGGTCAT CCCCTGCAAC GTCAGTGACT ATGATGGCCC CAGCGAGCAA
AACTTTGACT GGAGCTTCTC ATCTTTGGGG AGCAGCTTTG TGGAGCTTGC AAGCACCTGG
GAGGTGGGGT TCCCAGCCCA GCTGTACCAG GAGCGGCTGC AGAGGGGCGA GATCCTGTTA
AGGCGGACTG CCAACGACGC CGTGGAGCTC CACATAAAGA ACGTCCAGCC TTCAGACCAA
GGCCACTACA AATGTTCAAC CCCCAGCACA GATGCCACTG TCCAGGGAAA CTATGAGGAC
ACAGTGCAGG TTAAAGTGCT GGCCGACTCC CTGCACGTGG GCCCCAGCGC GCGGCCCCCG
CCGAGCCTGA GCCTGCGGGA GGGGGAGCCC TTCGAGCTGC GCTGCACCGC CGCCTCCGCC
TCGCCGCTGC ACACGCACCT GGCGCTGCTG TGGGAGGTGC ACCGCGGCCC GGCCAGGCGG
AGCGTCCTCG CCCTGACCCA CGAGGGCAGG TTCCACCCGG GCCTGGGGTA CGAGCAGCGC
TACCACAGTG GGGACGTGCG CCTCGACACC GTGGGCAGCG ACGCCTACCG CCTCTCAGTG
TCCCGGGCTC TGTCTGCCGA CCAGGGCTCC TACAGGTGTA TCGTCAGCGA GTGGATCGCC
GAGCAGGGCA ACTGGCAGGA AATCCAAGAA AAGGCCGTGG AAGTTGCCAC CGTGGTGATC
CAGCCATCAG TTCTGCGAGC AGCTGTGCCC AAGAATGTGT CTGTGGCTGA AGGAAAGGAA
CTGGACCTGA CCTGTAACAT CACAACAGAC CGAGCCGATG ACGTCCGGCC CGAGGTGACG
TGGTCCTTCA GCAGGATGCC TGACAGCACC CTACCTGGCT CCCGCGTGTT GGCGCGGCTT
GACCGTGATT CCCTGGTGCA CAGCTCGCCT CATGTTGCTT TGAGTCATGT GGATGCACGC
TCCTACCATT TACTGGTTCG GGATGTTAGC AAAGAAAACT CTGGCTACTA TTACTGCCAC
GTGTCCCTGT GGGCACCCGG ACACAACAGG AGCTGGCACA AAGTGGCAGA GGCCGTGTCT
TCCCCAGCTG GTGTGGGTGT GACCTGGCTA GAACCAGACT ACCAGGTGTA CCTGAATGCT
TCCAAGGTCC CCGGGTTTGC GGATGACCCC ACAGAGCTGG CATGCCGGGT GGTGGACACG
AAGAGTGGGG AGGCGAATGT CCGATTCACG GTTTCGTGGT ACTACAGGAT GAACCGGCGC
AGCGACAATG TGGTGACCAG CGAGCTGCTT GCAGTCATGG ACGGGGACTG GACGCTAAAA
TATGGAGAGA GGAGCAAGCA GCGGGCCCAG GATGGAGACT TTATTTTTTC TAAGGAACAT
ACAGACACGT TCAATTTCCG GATCCAAAGG ACTACAGAGG AAGACAGAGG CAATTATTAC
TGTGTTGTGT CTGCCTGGAC CAAACAGCGG AACAACAGCT GGGTGAAAAG CAAGGATGTC
TTCTCCAAGC CTGTTAACAT ATTTTGGGCA TTAGAAGATT CCGTGCTTGT GGTGAAGGCG
AGGCAGCCAA AGCCTTTCTT TGCTGCCGGA AATACATTTG AGATGACTTG CAAAGTATCT
TCCAAGAATA TTAAGTCGCC ACGCTACTCT GTTCTCATCA TGGCTGAGAA GCCTGTCGGC
GACCTCTCCA GTCCCAATGA AACGAAGTAC ATCATCTCTC TGGACCAGGA TTCTGTGGTG
AAGCTGGAGA ATTGGACAGA TGCATCACGG GTGGATGGCG TTGTTTTAGA AAAAGTGCAG
GAGGATGAGT TCCGCTATCG AATGTACCAG ACTCAGGTCT CAGACGCAGG GCTGTACCGC
TGCATGGTGA CAGCCTGGTC TCCTGTCAGG GGCAGCCTTT GGCGAGAAGC AGCAACCAGT
CTCTCCAATC CTATTGAGAT AGACTTCCAA ACCTCAGGTC CTATATTTAA TGCTTCTGTG
CATTCAGACA CACCATCAGT AATTCGGGGA GATCTGATCA AATTGTTCTG TATCATCACT
GTCGAGGGAG CAGCACTGGA TCCAGATGAC ATGGCCTTTG ATGTGTCCTG GTTTGCGGTG
CACTCTTTTG GCCTGGACAA GGCTCCTGTG CTCCTGTCTT CCCTGGATCG GAAGGGCATC
GTGACCACCT CCCGGAGGGA CTGGAAGAGC GACCTCAGCC TGGAGCGCGT GAGTGTGCTG
GAATTCTTGC TGCAAGTGCA TGGCTCCGAG GACCAGGACT TTGGCAACTA CTACTGTTCC
GTGACTCCAT GGGTGAAGTC ACCAACAGGT TCCTGGCAGA AGGAGGCAGA GATCCACTCC
AAGCCCGTTT TTATAACTGT GAAGATGGAT GTGCTGAACG CCTTCAAGTA TCCCTTGCTG
ATCGGCGTCG GTCTGTCCAC GGTCATCGGG CTCCTGTCCT GTCTCATCGG GTACTGCAGC
TCCCACTGGT GTTGTAAGAA GGAGGTTCAG GAGACACGGC GCGAGCGCCG CAGGCTCATG
TCGATGGAGA TGGACTAG

The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

book

CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth.
British journal of cancer104(3)496-504(2011 Feb)
Guilmain W,Colin S,Legrand E,Vannier JP,Steverlynck C,Bongaerts M,Vasse M,Al-Mahmood S


book

Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.
International journal of radiation oncology, biology, physics78(5)1292-300(2010 Dec)
Kerns SL,Ostrer H,Stock R,Li W,Moore J,Pearlman A,Campbell C,Shao Y,Stone N,Kusnetz L,Rosenstein BS


book

Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches.
Biological psychiatry67(3)263-9(2010 Feb)
Ikeda M,Tomita Y,Mouri A,Koga M,Okochi T,Yoshimura R,Yamanouchi Y,Kinoshita Y,Hashimoto R,Williams HJ,Takeda M,Nakamura J,Nabeshima T,Owen MJ,O'Donovan MC,Honda H,Arinami T,Ozaki N,Iwata N


book

In situ chemical cross-linking on living cells reveals CD9P-1 cis-oligomer at cell surface.
Journal of proteomics73(1)93-102(2009 Nov)
André M,Chambrion C,Charrin S,Soave S,Chaker J,Boucheix C,Rubinstein E,Le Naour F


book

Quantitative proteomics identifies a Dab2/integrin module regulating cell migration.
The Journal of cell biology186(1)99-111(2009 Jul)
Teckchandani A,Toida N,Goodchild J,Henderson C,Watts J,Wollscheid B,Cooper JA


 
*
*
*
*